Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Sarecycline in Acne Vulgaris
NCT02413346Phase 3Completed
- Sponsor
- Almirall
- Start
- Mar 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sarecycline in acne vulgaris, sponsored by Almirall. Started Mar 2015; status: completed.
02
Drugs
sarecycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02413346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02413346.